ExpressPoints: Caring for Patients Treated With Immune Checkpoint Inhibitors

In slides from Clinical Care Options (CCO), experts provide insights on the optimal use of immune checkpoint inhibitors for HCC and BTCs

R. Kate Kelley, MD Amit G. Singal, MD, MS Released: January 27, 2021

From Clinical Care Options, download slides reviewing the integration of CAR T-cell therapy into community care

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on the integration of CAR T-cell therapy into community care

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Asim V. Farooq, MD, and colleagues answer FAQs from a live CCO Webinar audience on ocular toxicity in patients receiving ADCs for multiple myeloma

Asim V. Farooq, MD
Program Director Sagar Lonial, MD Anthony Perissinotti, PharmD, BCOP Released: January 25, 2021